PET/CT assessment of symptomatic individuals with obstructive and nonobstructive hypertrophic cardiomyopathy

Journal of Nuclear Medicine

Volumn 53, Issue 3, 2012, Pages 407-414

  Bravo, Paco E ^a   Pinheiro, Aurélio ^a   Higuchi, Takahiro ^a   Rischpler, Christoph ^a   Merrill, Jennifer ^a   Santaularia Tomas, Miguel ^a   Abraham, M Roselle ^a   Wahl, Richard L ^a   Abraham, Theodore P ^a   Bengel, Frank M ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Hypertrophic cardiomyopathy; Myocardial blood flow; Outflow tract obstruction; PET

Indexed keywords

DIPYRIDAMOLE;

ADULT; AGE DISTRIBUTION; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; ECHOCARDIOGRAPHY; FEMALE; FRACTIONAL FLOW RESERVE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART MUSCLE BLOOD FLOW; HEART MUSCLE PERFUSION; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPEREMIA; HYPERTROPHIC CARDIOMYOPATHY; HYPERTROPHIC NONOBSTRUCTIVE CARDIOMYOPATHY; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; IMAGE ANALYSIS; MALE; MICROVASCULARIZATION; PHARMACOLOGIC STRESS TESTING; PRIORITY JOURNAL; SYMPTOMATOLOGY;

ADULT; AGED; ALGORITHMS; CARDIOMYOPATHY, HYPERTROPHIC; CORONARY CIRCULATION; DATA INTERPRETATION, STATISTICAL; DIPYRIDAMOLE; ELECTROCARDIOGRAPHY; FEMALE; HEART; HEMODYNAMICS; HUMANS; HYPEREMIA; HYPERTROPHY, LEFT VENTRICULAR; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; VASODILATOR AGENTS; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 84858602408     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.111.096156     Document Type: Article

References (37)

1. Maron BJ, McKenna WJ, Danielson GK, et al. American College of Cardiology/ European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol. 2003;42:1687-1713. (Pubitemid 37383745)
2. Maron MS, Olivotto I, Betocchi S, et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med. 2003;348:295-303. (Pubitemid 36119984)
3. Cecchi F, Olivotto I, Gistri R, Lorenzoni R, Chiriatti G, Camici PG. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med. 2003;349:1027-1035. (Pubitemid 37087617)
4. Olivotto I, Cecchi F, Gistri R, et al. Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2006;47:1043-1048.
5. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005; 18:1440-1463. (Pubitemid 41821197)
6. Czernin J, Muller P, Chan S, et al. Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation. 1993;88:62-69. (Pubitemid 23195433)
7. Rischpler C, Higuchi T, Fukushima K, Bravo PE, Merrill J, Bengel FM. Transient ischemic dilation ratio (TID) in rubidium-82 PET myocardial perfusion imaging: normal values and significance as a diagnostic and prognostic marker [abstract]. J Nucl Med. 2011;52(suppl 1):442.
8. Hutchins GD, Schwaiger M, Rosenspire KC, Krivokapich J, Schelbert H, Kuhl DE. Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol. 1990;15:1032-1042. (Pubitemid 20104558)
9. Hutchins GD, Caraher JM, Raylman RR. A region of interest strategy for minimizing resolution distortions in quantitative myocardial PET studies. J Nucl Med. 1992;33:1243-1250.
10. Burwash IG, Lortie M, Pibarot P, et al. Myocardial blood flow in patients with low-flow, low-gradient aortic stenosis: differences between true and pseudosevere aortic stenosis - results from the multicentre TOPAS (Truly or Pseudo- Severe Aortic Stenosis) study. Heart. 2008;94:1627-1633.
11. Hagege AA, Bruneval P, Levine RA, Desnos M, Neamatalla H, Judge DP. The mitral valve in hypertrophic cardiomyopathy: old versus new concepts. J Cardiovasc Transl Res. 2011;4:757-766.
12. Klues HG, Roberts WC, Maron BJ. Morphological determinants of echocardiographic patterns of mitral valve systolic anterior motion in obstructive hypertrophic cardiomyopathy. Circulation. 1993;87:1570-1579. (Pubitemid 23133102)
13. Kaple RK, Murphy RT, DiPaola LM, et al. Mitral valve abnormalities in hypertrophic cardiomyopathy: echocardiographic features and surgical outcomes. Ann Thorac Surg. 2008;85:1527-1535, 1535.e1-2.
14. Tanaka M, Fujiwara H, Onodera T, et al. Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts, and hearts with hypertrophic cardiomyopathy. Circulation. 1987;75:1130-1139. (Pubitemid 17081019)
15. Maron BJ, Wolfson JK, Epstein SE, Roberts WC. Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol. 1986;8:545-557. (Pubitemid 16048006)
16. Knaapen P, Germans T, Camici PG, et al. Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol. 2008;294:H986-H993. (Pubitemid 351253312)
17. Jörg-Ciopor M, Namdar M, Turina J, et al. Regional myocardial ischemia in hypertrophic cardiomyopathy: impact of myectomy. J Thorac Cardiovasc Surg. 2004;128:163-169. (Pubitemid 38969796)
18. Soliman OI, Knaapen P, Geleijnse ML, et al. Assessment of intravascular and extravascular mechanisms of myocardial perfusion abnormalities in obstructive hypertrophic cardiomyopathy by myocardial contrast echocardiography. Heart. 2007;93:1204-1212. (Pubitemid 47492903)
19. Cannon RO 3rd, Dilsizian V, O'Gara PT, et al. Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy. Circulation. 1991;83:1660-1667.
20. Ciampi Q, Betocchi S, Violante A, et al. Hemodynamic effects of isometric exercise in hypertrophic cardiomyopathy: comparison with normal subjects. J Nucl Cardiol. 2003;10:154-160. (Pubitemid 36503801)
21. Ciampi Q, Betocchi S, Losi MA, et al. Abnormal blood-pressure response to exercise and oxygen consumption in patients with hypertrophic cardiomyopathy. J Nucl Cardiol. 2007;14:869-875. (Pubitemid 350082579)
22. Okeie K, Shimizu M, Yoshio H, et al. Left ventricular systolic dysfunction during exercise and dobutamine stress in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2000;36:856-863.
23. Timmer SA, Knaapen P, Germans T, et al. Effects of alcohol septal ablation on coronary microvascular function and myocardial energetics in hypertrophic obstructive cardiomyopathy. Am J Physiol Heart Circ Physiol. 2011;301:H129-H137.
24. Petersen SE, Jerosch-Herold M, Hudsmith LE, et al. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging. Circulation. 2007;115:2418-2425. (Pubitemid 46717964)
25. Varnava AM, Elliott PM, Sharma S, McKenna WJ, Davies MJ. Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease. Heart. 2000;84:476-482.
26. Krams R, Kofflard MJ, Duncker DJ, et al. Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodeling of the coronary microcirculation. Circulation. 1998;97:230-233. (Pubitemid 28067305)
27. Graf S, Khorsand A, Gwechenberger M, et al. Typical chest pain and normal coronary angiogram: cardiac risk factor analysis versus PET for detection of microvascular disease. J Nucl Med. 2007;48:175-181. (Pubitemid 47555340)
28. Baller D, Notohamiprodjo G, Gleichmann U, Holzinger J, Weise R, Lehmann J. Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis. Circulation. 1999;99:2871-2875. (Pubitemid 29258974)
29. Higuchi T, Abletshauser C, Nekolla SG, Schwaiger M, Bengel FM. Effect of the angiotensin receptor blocker Valsartan on coronary microvascular flow reserve in moderately hypertensive patients with stable coronary artery disease. Microcirculation. 2007;14:805-812. (Pubitemid 350131388)
30. Tsukamoto T, Morita K, Naya M, et al. Myocardial flow reserve is influenced by both coronary artery stenosis severity and coronary risk factors in patients with suspected coronary artery disease. Eur J Nucl Med Mol Imaging. 2006;33:1150-1156. (Pubitemid 44484470)
31. Beanlands RS, Muzik O, Melon P, et al. Noninvasive quantification of regional myocardial flow reserve in patients with coronary atherosclerosis using nitrogen- 13 ammonia positron emission tomography: determination of extent of altered vascular reactivity. J Am Coll Cardiol. 1995;26:1465-1475.
32. Di Carli M, Czernin J, Hoh CK, et al. Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease. Circulation. 1995;91:1944-1951.
33. Olivotto I, Girolami F, Sciagra R, et al. Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations. J Am Coll Cardiol. 2011;58:839-848.
34. Prasad K, Frenneaux MP. Sudden death in hypertrophic cardiomyopathy: potential importance of altered autonomic control of vasculature. Heart. 1998;79:538-540. (Pubitemid 28289273)
35. Gilligan DM, Nihoyannopoulos P, Chan WL, Oakley CM. Investigation of a hemodynamic basis for syncope in hypertrophic cardiomyopathy: use of a head-up tilt test. Circulation. 1992;85:2140-2148.
36. Li ST, Tack CJ, Fananapazir L, Goldstein DS. Myocardial perfusion and sympathetic innervation in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2000;35:1867-1873. (Pubitemid 30342869)
37. Maron MS, Olivotto I, Zenovich AG, et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation. 2006;114:2232-2239. (Pubitemid 44789498)